Western General Hospital
Consultant Haematologist
Haematology
Western General Hospital
NHS Lothian is committed to encouraging equality and diversity among our workforce and eliminating unlawful discrimination. The aim is for our workforce to be truly representative and for each employee to feel respected and able to give their best.
To this end, NHS Lothian welcomes applications from all sections of society.
We will fully support disabled candidates, and candidates with long-term conditions or who are neurodivergent by making reasonable adjustments to our recruitment policy and practices.
MEDICAL
Applicants must have full GMC Registration, a license to practice and eligible for inclusion in the GMC Specialist Register. Those trained in the UK should have evidence of higher specialist training leading to CCT or be within 6 months of confirmed entry from the date of interview. Portfolio Pathway (formerly known as CESR - Certificate of Eligibility for Specialist Registration) route doctors are only eligible to apply for a substantive consultant post once it has been awarded. Non-UK applicants must demonstrate equivalent training.
Applications are welcome for the above Permanent (40hours per week) post based in Western General Hospital.
You may also be required to work at any of NHS Lothian sites.
Post Summary:
Applications are invited from registered medical practitioners for the post of Consultant
Haematologist based within the Edinburgh Cancer Centre, Western General Hospital (WGH), Edinburgh. This is a 10 programmed activity position available immediately. This post will include an on-call commitment at the WGH for out-of-hours including haemato-oncology cover for NHS Lothian and NHS Borders.
The main objectives of the post are:
1. Provision of clinical and laboratory haematology services in collaboration with existing consultants
2. To play a significant role in ensuring provision of high-quality Haematology Laboratory Services within the WGH
3. To be research active and contribute to the expansion of the departments clinical trials programme
4. Sub-specialty emphasis in an area of bone marrow or myeloid malignancies (principally myeloma, and leukaemia/myelodsplasia/myeloproliferative neoplasms). Interests can be developed that complement existing expertise in the team. Two similar posts are being advertised in parallel
5. Contribution to teaching/training, audit and managerial responsibilities as appropriate to experience